Skip to main content
Neuland Labs
Menu
Search
Search
Main navigation
CDMO Services
CDMO Services sub-navigation
Small Molecules
Peptides
Generic APIs
Generic APIs sub-navigation
API Products
Download Brochure
Our Capabilities
Our Capabilities sub-navigation
Chemistry & Reactions
Peptide Technologies
Lifecycle Management (Phase-Appropriate Development)
Quality & Regulatory Compliance
Technology Transfer
Analytical Expertise
Process Safety & Engineering
Contact us
Search
Search
User account menu
Log in
Breadcrumb
Home
Audited Financial Results (Consolidated and Standalone) for Q4FY 2023
By
Anonymous (not verified)
, 27 July, 2026
Quarterly Results
2022-23
Q4
PDF
nllq4fy23.pdf
(9.49 MB)
RSS feed